Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today issued the following comments in response to inquiries from investors regarding Deb Jorn's departure from Valeant.nnIt is our understanding that Deb Jorn decided to leave Valeant for personal reasons. Her departure is not the result of an action taken by the Ad Hoc Committee of the Board of Directors.